CORE: Cytometry and Cell Sorting Shared Resource (Cell and in vivo Biology Group) PROJECT SUMMARY Flow cytometry is an essential and broadly applicable technology for cancer research to assist with elucidating mechanisms of tumor suppressor and oncogenes, cell-cycle progression, transforming viruses, and to evaluate cancer therapies. It is also integral to studies of cancer stem cells, angiogenesis, inflammation, transcriptional regulation in tumor cells and mechanisms of DNA break and repair. The goal of the Cytometry and Cell Sorting Shared Resource (CCSSR) is to provide a wide range of cancer center investigators with access to cost-effective state-of-the-art instrumentation, expertise and training for their cell sorting and analysis needs. This technology continues to develop at a rapid pace, especially with the advent of novel tools and reagents, increased computational capacity and more cost-effective optical equipment. To keep pace with changing technologies and growth of users over the past 4 years, the CCSSR has expanded its space with new lab renovations, added a satellite facility at our affiliated Texas Childrens Hospital Cancer Center and acquired substantial upgrades of previously exsiting equipment and acquired additional new major equipment. The main facility is housed in centrally located space and is available to trained users 24 hours a day, seven days a week by key-card access. Current major instrumentation includes four fully florescence-activated cell sorters, six flow analyzers and magnetic- and microfluidic-based cell sorters. The Resource is directed by Dr. Christine Beeton and Mr. Joel Sederstrom, who have over ten and 15 years of experience in flow cytometry respectively, and is staffed by three full-time experienced flow cytometrists who perform operator-assisted cytometry, and assist users with data analysis. To ensure optimal use of services, CCSSR provides consultations, individually- tailored training, and protocols for sample preparation, flow analysis and cell sorting. This is a heavily used Shared Resource that provided service for 125 Cancer Center investigators during the last year, a substantial increase from 83 users in the first year of the CCSG award. Future plans include addition of new technologies and instrumentation for image- and mass-based cytometry that are pushing the boundaries of conventional flow cytometry and further expansion of space and research staff required for these new technologies and anticipated continued growth of CCSSR.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-13
Application #
9759804
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
13
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Sukumaran, Sujita; Watanabe, Norihiro; Bajgain, Pradip et al. (2018) Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discov 8:972-987
Kaochar, Salma; Mitsiades, Nicholas (2018) A Novel Mechanism to Drive Castration-Resistant Prostate Cancer. Trends Endocrinol Metab 29:366-368
Boudreaux, Seth P; Duren, Ryan P; Call, Steven G et al. (2018) Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia :
Ostrom, Quinn T; Kinnersley, Ben; Wrensch, Margaret R et al. (2018) Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. Sci Rep 8:7352
Chen, Fengju; Zhang, Yiqun; Varambally, Sooryanarayana et al. (2018) Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas. Mol Cancer Res :
Johnston, A N; Bu, W; Hein, S et al. (2018) Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Res 20:42
Bajgain, Pradip; Tawinwung, Supannikar; D'Elia, Lindsey et al. (2018) CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation. J Immunother Cancer 6:34
Badr, Hoda; Herbert, Krista; Bonnen, Mark D et al. (2018) Dyadic Coping in Patients Undergoing Radiotherapy for Head and Neck Cancer and Their Spouses. Front Psychol 9:1780
Morita, Daisuke; Nishio, Nobuhiro; Saito, Shoji et al. (2018) Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells. Mol Ther Methods Clin Dev 8:131-140
Gates, Leah A; Gu, Guowei; Chen, Yue et al. (2018) Proteomic profiling identifies key coactivators utilized by mutant ER? proteins as potential new therapeutic targets. Oncogene 37:4581-4598

Showing the most recent 10 out of 991 publications